Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05098665Not ApplicableRecruiting

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

Role: lead

NCT04404062Recruiting

Serological and PCR Testing for COVID-19

Role: lead

NCT04873258Recruiting

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease

Role: lead

NCT07014735Not ApplicableRecruiting

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Role: collaborator

NCT06809686Recruiting

Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care

Role: lead

NCT01984827Phase 1Completed

Effect of Glucose on QTc Interval in Type 1 Diabetes

Role: lead

All 6 trials loaded